Mibefradil (Posicor)

• Ca2+-channel blocker

• CYP 3A4 inhibitor

  • In vitro, inhibited metabolism of simvastatin, lovastatin, atorvastatin, cerivastatin (Ki < 1 µM)
  • No statin-associated events seen in phase III

Previous slide

Next slide

Back to first slide

View graphic version